A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy
Public ClinicalTrials.gov record NCT02288559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Randomized, Single-Masked, Sham Injection-Controlled Exposure-Response Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Patients With Geographic Atrophy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multicenter, randomized, single-masked, sham injection-controlled study will investigate the exposure-response and safety of lampalizumab administered intravitreally every 2 weeks (Q2W) or every 4 weeks (Q4W) for 24 weeks in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). A safety run-in assessment will be conducted prior to initiating enrollment in the randomized study.
Study identification
- NCT ID
- NCT02288559
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 96 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 30, 2015 (Actual)
- Primary completion
- Jun 2, 2017 (Actual)
- Completion
- Jun 2, 2017 (Actual)
- Last update posted
- Sep 25, 2019
2015 – 2017
United States locations
- U.S. sites
- 36
- U.S. states
- 19
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barnet Dulaney Perkins Eye Center | Mesa | Arizona | 85206 | — |
| University of Arizona; Banner University Medical, Department of Opthalmology | Tucson | Arizona | 85711 | — |
| Northwest Arkansas Retina Associates | Springdale | Arkansas | 72764 | — |
| Retinal Diagnostic Center | Campbell | California | 95008 | — |
| The Retina Partners | Encino | California | 91436 | — |
| Loma Linda University | Loma Linda | California | 92354 | — |
| San Diego Retina Associates | Oceanside | California | 92056 | — |
| West Coast Retina Medical Group | San Francisco | California | 94109 | — |
| California Retina Consultants | Santa Barbara | California | 93103 | — |
| Colorado Retina Associates, PC | Golden | Colorado | 80401 | — |
| Florida Eye Microsurgical Inst | Boynton Beach | Florida | 33426 | — |
| National Ophthalmic Research Institute | Fort Myers | Florida | 33912 | — |
| Florida Eye Associates | Melbourne | Florida | 32901 | — |
| Retina Care Specialists | Palm Beach Gardens | Florida | 33410 | — |
| Retina Specialty Institute | Pensacola | Florida | 32503 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Wolfe Eye Clinic | West Des Moines | Iowa | 50266 | — |
| Elman Retina Group | Baltimore | Maryland | 21237 | — |
| Vitreoretinal Surgery | Edina | Minnesota | 55435 | — |
| The Retina Institute | St Louis | Missouri | 63128 | — |
| Sierra Eye Associates | Reno | Nevada | 89502 | — |
| Eye Associates of New Mexico | Albuquerque | New Mexico | 87102 | — |
| Western Carolina Retinal Associate PA | Asheville | North Carolina | 28803 | — |
| Char Eye Ear &Throat Assoc | Charlotte | North Carolina | 28210 | — |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | — |
| Retina Assoc of Cleveland Inc | Cleveland | Ohio | 44122 | — |
| Dean McGee Eye Institute | Oklahoma City | Oklahoma | 73099 | — |
| Retina Cons of Charleston | Charleston | South Carolina | 29414 | — |
| Carolina Retina Center PA | Columbia | South Carolina | 29223 | — |
| Charles Retina Institution | Germantown | Tennessee | 38138 | — |
| Southeastern Retina Associates | Knoxville | Tennessee | 37923 | — |
| Tennessee Retina PC. | Nashville | Tennessee | 37203 | — |
| W Texas Retina Consultants PA | Abilene | Texas | 79606 | — |
| Texas Retina Associates | Dallas | Texas | 75231 | — |
| Retina Specialists | DeSoto | Texas | 75115 | — |
| Wagner Macula & Retina Center | Norfolk | Virginia | 23451 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02288559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2019 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02288559 live on ClinicalTrials.gov.